Global Carbon-14 Radiosynthesis Services Market Growth (Status and Outlook) 2026-2032
The global Carbon-14 Radiosynthesis Services market size is predicted to grow from US$ 223 million in 2025 to US$ 322 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.
Carbon-14 Radiosynthesis Services refer to specialized technical services that design and execute the synthesis of compounds labeled with the radioactive isotope carbon-14 (??C) for scientific research, drug development, and industrial applications. These services, typically offered by contract research organizations (CROs), academic research institutions, or specialized biotech service providers, follow custom-tailored workflows: they first select appropriate ??C precursors (e.g., sodium acetate-1-??C, potassium cyanide-??C) based on the target compound’s structure and client needs, then use chemical reactions like carbon-carbon bond formation, oxidation, or reduction to covalently incorporate ??C into specific positions of the molecule—ensuring the isotope’s stability and retention throughout the synthesis process. Ultimately, the ??C-labeled compounds produced through these services enable clients (pharmaceutical companies, research labs, environmental agencies) to track molecular pathways, study long-term drug absorption, distribution, metabolism, and excretion (ADME) in preclinical and clinical studies, or analyze environmental pollutant degradation and carbon cycling in ecological research.
Key Findings
Carbon-14 remains preferred for pharmaceutical mass balance studies
GMP projects require expanded documentation testing and release controls
Pharmaceutical and biotechnology applications represent the largest demand segment
North America leads demand while Europe anchors specialist supply
Integrated radiosynthesis and ADME platforms strengthen provider differentiation
Complex peptides and conjugates expand high-value project opportunities
Market Trends
The Carbon-14 Radiosynthesis Services market is moving from isolated custom synthesis assignments toward integrated radiolabelled development programs that connect route design, isotope incorporation, analytical release, formulation, preclinical ADME, human mass-balance studies and metabolite identification. Pharmaceutical customers increasingly involve radiochemists earlier in development so that the carbon-14 position remains metabolically stable, the synthesis route can use commercially accessible radioactive precursors and sufficient material can be produced for successive study stages. Demand is also shifting toward more complex molecules, including chiral compounds, peptides, linker-payload structures, antibody-drug conjugates and other new therapeutic modalities that require expertise across synthetic chemistry, bioconjugation, purification and radioanalysis. Suppliers are strengthening capabilities for GMP production, low-activity clinical materials, microtracer programs and integrated accelerated mass spectrometry workflows. Digital batch records, electronic analytical data packages and stronger chain-of-custody documentation are becoming more important as projects move between synthesis laboratories, clinical units and analytical facilities. Carbon-14 remains the principal isotope for many mass-balance applications because it can be incorporated into the molecular carbon skeleton without materially changing the structure and has a sufficiently long half-life for extended development programs.
Market Dynamics
Drivers
The most important demand driver is the continuing regulatory role of radiolabelled mass-balance and ADME studies in drug development. The US Food and Drug Administration states that human radiolabelled mass-balance studies are generally needed for new molecular entities because they clarify absorption, metabolic pathways, routes of elimination, total recovery and the need for additional metabolite safety evaluation. Carbon-14 accounted for 103 of 104 human radiolabelled mass-balance studies examined in an FDA-associated analysis, confirming its position as the dominant tracer for this application. Demand is also supported by crop-protection and environmental registration requirements. OECD crop and livestock metabolism guidelines specify radiolabelled test substances and identify carbon-14 as the preferred isotope for tracing residues, metabolites and degradation products. Growth in pharmaceutical pipelines, outsourcing by emerging biotechnology companies, environmental-fate testing and regulatory expectations for comprehensive metabolite characterization therefore supports recurring demand for specialized synthesis capacity.
Restraints
Market expansion is restrained by the technical complexity, long project cycles and limited availability of specialized infrastructure and personnel. Carbon-14 synthesis cannot always follow the established non-radioactive medicinal chemistry route because the number of commercially available carbon-14 building blocks is restricted and the label must be inserted at a position that remains stable during metabolism or environmental degradation. Low-yield reactions, radioactive waste generation, radiolytic degradation and losses during multistep purification can materially increase project cost. Providers must maintain licensed radioactive-material facilities, contamination controls, specialist analytical instruments, qualified personnel and compliant waste-management procedures even when project utilization fluctuates. International shipment also requires approved packaging, documentation and coordination with carriers and national authorities. These requirements create substantial entry barriers but can also limit capacity, extend lead times and complicate cross-border project scheduling.
Opportunities
The strongest opportunities lie in integrated development programs, GMP clinical supply and complex-molecule radiolabelling. Providers able to combine radiosynthetic chemistry with formulation, toxicology support, nonclinical ADME, human mass-balance studies, metabolite profiling and bioanalysis can capture a larger share of each drug-development program and reduce handoff risks for clients. New modalities create additional opportunities because peptides, oligonucleotide-related structures, antibody-drug conjugates and targeted delivery systems often require site-specific or multisite labelling strategies and specialized purification. Carbon-14 synthesis for low-dose microtracer and absolute bioavailability studies is another attractive field, particularly when combined with accelerated mass spectrometry. Agrochemical, biocide and specialty chemical customers also provide diversification beyond pharmaceuticals because carbon-14 remains important for crop metabolism, livestock metabolism, soil degradation, water studies and environmental-fate assessment. Asian CROs with integrated chemistry and DMPK platforms are positioned to gain projects from global biotechnology companies seeking coordinated execution and competitive development timelines.
Challenges
The principal challenge is consistently delivering material that satisfies chemical, radiochemical and regulatory specifications despite the small quantities and complex reaction routes involved. A successful project must control label position, specific activity, chemical purity, radiochemical purity, stereochemical integrity, residual solvents, stability and formulation compatibility. Clinical projects impose additional requirements for protocol control, validated or qualified analytical methods, batch documentation, change management and formal release. Project delays may occur when a proposed labelling route proves unsuitable, an intermediate is unstable, purification recovery is low or insufficient radioactive precursor is available. Providers also face radiation-safety risk, environmental liability and a shortage of experienced radiochemists. Intellectual-property protection is particularly important because clients often disclose proprietary structures and unpublished synthetic routes. Finally, dependence on a limited number of specialist facilities can create supply-chain concentration risk if a laboratory experiences licensing delays, equipment downtime, contamination events or transport disruption.
Value Chain Analysis
The upstream value chain includes carbon-14 raw materials and labelled building blocks, non-radioactive starting materials, solvents, reagents, chromatography media, analytical standards, radioactive-material packaging and specialist laboratory equipment. Critical equipment includes controlled radiochemistry workstations, fume hoods or containment systems, preparative chromatography, radio-HPLC, liquid scintillation counters, mass spectrometers, NMR systems and stability-storage facilities. Upstream value is also created by radiation licensing, personnel training, dosimetry, waste disposal and qualified logistics services. The limited availability of suitable carbon-14 precursors makes procurement strategy and route planning important determinants of project economics.
Midstream service providers perform feasibility assessment, label-position selection, cold-route development, radioactive precursor preparation, carbon-14 incorporation, purification, characterization, stability testing, formulation and batch release. Non-GMP materials are mainly used in discovery, preclinical ADME, environmental-fate and research studies, while GMP-compliant materials support human clinical administration. Downstream customers include pharmaceutical and biotechnology companies, agrochemical manufacturers, contract research organizations, specialty chemical companies, universities and regulatory laboratories. The highest value is created when the radiosynthesis provider integrates chemistry with analytical release and downstream study execution, thereby reducing material transfers, timeline uncertainty and responsibility gaps between multiple contractors.
Segment Insights
By quality standard, the market is divided into GMP-Compliant Services and Non-GMP Services. GMP-Compliant Services cover carbon-14 labelled APIs, clinical drug substances and other materials produced under controlled quality systems for human administration in mass-balance, microdosing or related clinical studies. These projects require formal manufacturing instructions, controlled raw materials, documented deviations, stability assessment, comprehensive analytical release and traceable packaging. GMP projects account for a smaller number of contracts but generally carry higher average project values because of the additional quality, analytical and regulatory workload. Providers with dedicated licensed GMP radiochemistry facilities and established regulatory inspection histories have a defensible competitive advantage in this segment.
Non-GMP Services account for the larger share of project volume and cover discovery compounds, preclinical ADME materials, metabolites, reference standards, agrochemical test substances, environmental-fate materials and exploratory research compounds. The segment is more diverse in molecular structure, quantity and analytical requirements, with competition based on synthetic problem-solving, delivery time, purity and cost.
Downstream Market Opportunities
Pharmaceutical and biotechnology companies represent the largest downstream customer group. Carbon-14 labelled compounds are used in nonclinical and human ADME, mass balance, metabolite profiling, tissue distribution, absolute bioavailability, drug-drug interaction support and the evaluation of peptides, conjugates and other complex modalities. Demand is concentrated around clinical-development milestones because the radiolabelled batch must be available before the corresponding study can begin. Small and medium biotechnology companies create attractive outsourcing opportunities because they rarely maintain internal licensed radiochemistry facilities. Crop-protection companies form the second major application group, using carbon-14 materials in plant metabolism, livestock metabolism, rotational-crop, soil, water and environmental-fate studies. Specialty chemicals, biocides, cosmetics, academic research and industrial toxicology provide additional demand. Providers that can supply both labelled material and the associated analytical or ADME study are better positioned to secure recurring programs and become embedded in customer development workflows.
Regional Insights
North America is assessed as the largest demand region, supported by the scale of pharmaceutical and biotechnology research, FDA expectations for human radiolabelled mass-balance studies and a substantial crop-protection testing industry. The region also hosts established providers such as Revvity, Moravek, American Radiolabeled Chemicals and Labcorp. Competition ranges from specialist radiochemical manufacturers to integrated CRO platforms, while US radioactive-material licensing and transport requirements create significant compliance barriers.
Europe is the principal specialist supply cluster and contains experienced carbon-14 chemistry operations in the United Kingdom, Sweden and Germany. Eurofins-owned Selcia, Almac, Novandi Chemistry and Nuvisan provide capabilities spanning custom synthesis, GMP manufacture, isotope chemistry and integrated DMPK support. Europe also benefits from extensive pharmaceutical, agrochemical and chemical-regulation demand. Asia Pacific is the fastest-developing regional supply base, led by China-based integrated CROs such as Pharmaron and WuXi AppTec, together with specialist providers such as Beita Pharmatech. Japan, South Korea and Taiwan remain important end-user markets but have fewer internationally visible independent carbon-14 radiosynthesis facilities, resulting in greater reliance on overseas or integrated global suppliers.
Report Scope
LPI (LP Information)' newest research report, the “Carbon-14 Radiosynthesis Services Industry Forecast” looks at past sales and reviews total world Carbon-14 Radiosynthesis Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Carbon-14 Radiosynthesis Services sales for 2026 through 2032. With Carbon-14 Radiosynthesis Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Carbon-14 Radiosynthesis Services industry.
This Insight Report provides a comprehensive analysis of the global Carbon-14 Radiosynthesis Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Carbon-14 Radiosynthesis Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Carbon-14 Radiosynthesis Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Carbon-14 Radiosynthesis Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Carbon-14 Radiosynthesis Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Carbon-14 Radiosynthesis Services market by product type, application, key players and key regions and countries.
Carbon-14 Radiosynthesis Services refer to specialized technical services that design and execute the synthesis of compounds labeled with the radioactive isotope carbon-14 (??C) for scientific research, drug development, and industrial applications. These services, typically offered by contract research organizations (CROs), academic research institutions, or specialized biotech service providers, follow custom-tailored workflows: they first select appropriate ??C precursors (e.g., sodium acetate-1-??C, potassium cyanide-??C) based on the target compound’s structure and client needs, then use chemical reactions like carbon-carbon bond formation, oxidation, or reduction to covalently incorporate ??C into specific positions of the molecule—ensuring the isotope’s stability and retention throughout the synthesis process. Ultimately, the ??C-labeled compounds produced through these services enable clients (pharmaceutical companies, research labs, environmental agencies) to track molecular pathways, study long-term drug absorption, distribution, metabolism, and excretion (ADME) in preclinical and clinical studies, or analyze environmental pollutant degradation and carbon cycling in ecological research.
Key Findings
Carbon-14 remains preferred for pharmaceutical mass balance studies
GMP projects require expanded documentation testing and release controls
Pharmaceutical and biotechnology applications represent the largest demand segment
North America leads demand while Europe anchors specialist supply
Integrated radiosynthesis and ADME platforms strengthen provider differentiation
Complex peptides and conjugates expand high-value project opportunities
Market Trends
The Carbon-14 Radiosynthesis Services market is moving from isolated custom synthesis assignments toward integrated radiolabelled development programs that connect route design, isotope incorporation, analytical release, formulation, preclinical ADME, human mass-balance studies and metabolite identification. Pharmaceutical customers increasingly involve radiochemists earlier in development so that the carbon-14 position remains metabolically stable, the synthesis route can use commercially accessible radioactive precursors and sufficient material can be produced for successive study stages. Demand is also shifting toward more complex molecules, including chiral compounds, peptides, linker-payload structures, antibody-drug conjugates and other new therapeutic modalities that require expertise across synthetic chemistry, bioconjugation, purification and radioanalysis. Suppliers are strengthening capabilities for GMP production, low-activity clinical materials, microtracer programs and integrated accelerated mass spectrometry workflows. Digital batch records, electronic analytical data packages and stronger chain-of-custody documentation are becoming more important as projects move between synthesis laboratories, clinical units and analytical facilities. Carbon-14 remains the principal isotope for many mass-balance applications because it can be incorporated into the molecular carbon skeleton without materially changing the structure and has a sufficiently long half-life for extended development programs.
Market Dynamics
Drivers
The most important demand driver is the continuing regulatory role of radiolabelled mass-balance and ADME studies in drug development. The US Food and Drug Administration states that human radiolabelled mass-balance studies are generally needed for new molecular entities because they clarify absorption, metabolic pathways, routes of elimination, total recovery and the need for additional metabolite safety evaluation. Carbon-14 accounted for 103 of 104 human radiolabelled mass-balance studies examined in an FDA-associated analysis, confirming its position as the dominant tracer for this application. Demand is also supported by crop-protection and environmental registration requirements. OECD crop and livestock metabolism guidelines specify radiolabelled test substances and identify carbon-14 as the preferred isotope for tracing residues, metabolites and degradation products. Growth in pharmaceutical pipelines, outsourcing by emerging biotechnology companies, environmental-fate testing and regulatory expectations for comprehensive metabolite characterization therefore supports recurring demand for specialized synthesis capacity.
Restraints
Market expansion is restrained by the technical complexity, long project cycles and limited availability of specialized infrastructure and personnel. Carbon-14 synthesis cannot always follow the established non-radioactive medicinal chemistry route because the number of commercially available carbon-14 building blocks is restricted and the label must be inserted at a position that remains stable during metabolism or environmental degradation. Low-yield reactions, radioactive waste generation, radiolytic degradation and losses during multistep purification can materially increase project cost. Providers must maintain licensed radioactive-material facilities, contamination controls, specialist analytical instruments, qualified personnel and compliant waste-management procedures even when project utilization fluctuates. International shipment also requires approved packaging, documentation and coordination with carriers and national authorities. These requirements create substantial entry barriers but can also limit capacity, extend lead times and complicate cross-border project scheduling.
Opportunities
The strongest opportunities lie in integrated development programs, GMP clinical supply and complex-molecule radiolabelling. Providers able to combine radiosynthetic chemistry with formulation, toxicology support, nonclinical ADME, human mass-balance studies, metabolite profiling and bioanalysis can capture a larger share of each drug-development program and reduce handoff risks for clients. New modalities create additional opportunities because peptides, oligonucleotide-related structures, antibody-drug conjugates and targeted delivery systems often require site-specific or multisite labelling strategies and specialized purification. Carbon-14 synthesis for low-dose microtracer and absolute bioavailability studies is another attractive field, particularly when combined with accelerated mass spectrometry. Agrochemical, biocide and specialty chemical customers also provide diversification beyond pharmaceuticals because carbon-14 remains important for crop metabolism, livestock metabolism, soil degradation, water studies and environmental-fate assessment. Asian CROs with integrated chemistry and DMPK platforms are positioned to gain projects from global biotechnology companies seeking coordinated execution and competitive development timelines.
Challenges
The principal challenge is consistently delivering material that satisfies chemical, radiochemical and regulatory specifications despite the small quantities and complex reaction routes involved. A successful project must control label position, specific activity, chemical purity, radiochemical purity, stereochemical integrity, residual solvents, stability and formulation compatibility. Clinical projects impose additional requirements for protocol control, validated or qualified analytical methods, batch documentation, change management and formal release. Project delays may occur when a proposed labelling route proves unsuitable, an intermediate is unstable, purification recovery is low or insufficient radioactive precursor is available. Providers also face radiation-safety risk, environmental liability and a shortage of experienced radiochemists. Intellectual-property protection is particularly important because clients often disclose proprietary structures and unpublished synthetic routes. Finally, dependence on a limited number of specialist facilities can create supply-chain concentration risk if a laboratory experiences licensing delays, equipment downtime, contamination events or transport disruption.
Value Chain Analysis
The upstream value chain includes carbon-14 raw materials and labelled building blocks, non-radioactive starting materials, solvents, reagents, chromatography media, analytical standards, radioactive-material packaging and specialist laboratory equipment. Critical equipment includes controlled radiochemistry workstations, fume hoods or containment systems, preparative chromatography, radio-HPLC, liquid scintillation counters, mass spectrometers, NMR systems and stability-storage facilities. Upstream value is also created by radiation licensing, personnel training, dosimetry, waste disposal and qualified logistics services. The limited availability of suitable carbon-14 precursors makes procurement strategy and route planning important determinants of project economics.
Midstream service providers perform feasibility assessment, label-position selection, cold-route development, radioactive precursor preparation, carbon-14 incorporation, purification, characterization, stability testing, formulation and batch release. Non-GMP materials are mainly used in discovery, preclinical ADME, environmental-fate and research studies, while GMP-compliant materials support human clinical administration. Downstream customers include pharmaceutical and biotechnology companies, agrochemical manufacturers, contract research organizations, specialty chemical companies, universities and regulatory laboratories. The highest value is created when the radiosynthesis provider integrates chemistry with analytical release and downstream study execution, thereby reducing material transfers, timeline uncertainty and responsibility gaps between multiple contractors.
Segment Insights
By quality standard, the market is divided into GMP-Compliant Services and Non-GMP Services. GMP-Compliant Services cover carbon-14 labelled APIs, clinical drug substances and other materials produced under controlled quality systems for human administration in mass-balance, microdosing or related clinical studies. These projects require formal manufacturing instructions, controlled raw materials, documented deviations, stability assessment, comprehensive analytical release and traceable packaging. GMP projects account for a smaller number of contracts but generally carry higher average project values because of the additional quality, analytical and regulatory workload. Providers with dedicated licensed GMP radiochemistry facilities and established regulatory inspection histories have a defensible competitive advantage in this segment.
Non-GMP Services account for the larger share of project volume and cover discovery compounds, preclinical ADME materials, metabolites, reference standards, agrochemical test substances, environmental-fate materials and exploratory research compounds. The segment is more diverse in molecular structure, quantity and analytical requirements, with competition based on synthetic problem-solving, delivery time, purity and cost.
Downstream Market Opportunities
Pharmaceutical and biotechnology companies represent the largest downstream customer group. Carbon-14 labelled compounds are used in nonclinical and human ADME, mass balance, metabolite profiling, tissue distribution, absolute bioavailability, drug-drug interaction support and the evaluation of peptides, conjugates and other complex modalities. Demand is concentrated around clinical-development milestones because the radiolabelled batch must be available before the corresponding study can begin. Small and medium biotechnology companies create attractive outsourcing opportunities because they rarely maintain internal licensed radiochemistry facilities. Crop-protection companies form the second major application group, using carbon-14 materials in plant metabolism, livestock metabolism, rotational-crop, soil, water and environmental-fate studies. Specialty chemicals, biocides, cosmetics, academic research and industrial toxicology provide additional demand. Providers that can supply both labelled material and the associated analytical or ADME study are better positioned to secure recurring programs and become embedded in customer development workflows.
Regional Insights
North America is assessed as the largest demand region, supported by the scale of pharmaceutical and biotechnology research, FDA expectations for human radiolabelled mass-balance studies and a substantial crop-protection testing industry. The region also hosts established providers such as Revvity, Moravek, American Radiolabeled Chemicals and Labcorp. Competition ranges from specialist radiochemical manufacturers to integrated CRO platforms, while US radioactive-material licensing and transport requirements create significant compliance barriers.
Europe is the principal specialist supply cluster and contains experienced carbon-14 chemistry operations in the United Kingdom, Sweden and Germany. Eurofins-owned Selcia, Almac, Novandi Chemistry and Nuvisan provide capabilities spanning custom synthesis, GMP manufacture, isotope chemistry and integrated DMPK support. Europe also benefits from extensive pharmaceutical, agrochemical and chemical-regulation demand. Asia Pacific is the fastest-developing regional supply base, led by China-based integrated CROs such as Pharmaron and WuXi AppTec, together with specialist providers such as Beita Pharmatech. Japan, South Korea and Taiwan remain important end-user markets but have fewer internationally visible independent carbon-14 radiosynthesis facilities, resulting in greater reliance on overseas or integrated global suppliers.
Report Scope
LPI (LP Information)' newest research report, the “Carbon-14 Radiosynthesis Services Industry Forecast” looks at past sales and reviews total world Carbon-14 Radiosynthesis Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Carbon-14 Radiosynthesis Services sales for 2026 through 2032. With Carbon-14 Radiosynthesis Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Carbon-14 Radiosynthesis Services industry.
This Insight Report provides a comprehensive analysis of the global Carbon-14 Radiosynthesis Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Carbon-14 Radiosynthesis Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Carbon-14 Radiosynthesis Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Carbon-14 Radiosynthesis Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Carbon-14 Radiosynthesis Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Carbon-14 Radiosynthesis Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
- GMP - Compliant Services
- Non - GMP Services
Segmentation by Compounds Type:
- Volatile Compounds
- Aromatics and Heterocyclics
- Other
Segmentation by Detection Method:
- Liquid Scintillation and Solid Scintillation Methods
- Ionization Method
Segmentation by Application:
- Medical
- Chemical Research
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eurofins
- Revvity
- Selcia
- Novandi Chemistry
- Almac
- Pharmaron
- WuXi AppTec
- Nuvisan
- Alfa Cytology
- Headway
- ViTrax
- Beita Pharmatech Co., Ltd.
- Moravek, Inc.
- Labcorp
- American Radiolabeled Chemicals, Inc.
- Frontage Laboratories
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Carbon-14 Radiosynthesis Services Market Size (2021-2032)
2.1.2 Carbon-14 Radiosynthesis Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Carbon-14 Radiosynthesis Services by Country/Region (2021, 2025 & 2032)
2.2 Carbon-14 Radiosynthesis Services Segment by Type
2.2.1 GMP - Compliant Services
2.2.2 Non - GMP Services
2.2.3 Carbon-14 Radiosynthesis Services Market Size by Type
2.2.3.1 Carbon-14 Radiosynthesis Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
2.3 Carbon-14 Radiosynthesis Services Segment by Compounds Type
2.3.1 Volatile Compounds
2.3.2 Aromatics and Heterocyclics
2.3.3 Other
2.3.4 Carbon-14 Radiosynthesis Services Market Size by Compounds Type
2.3.4.1 Carbon-14 Radiosynthesis Services Market Size CAGR by Compounds Type (2021 VS 2025 VS 2032)
2.3.4.2 Global Carbon-14 Radiosynthesis Services Market Size Market Share by Compounds Type (2021-2026)
2.4 Carbon-14 Radiosynthesis Services Segment by Detection Method
2.4.1 Liquid Scintillation and Solid Scintillation Methods
2.4.2 Ionization Method
2.4.3 Carbon-14 Radiosynthesis Services Market Size by Detection Method
2.4.3.1 Carbon-14 Radiosynthesis Services Market Size CAGR by Detection Method (2021 VS 2025 VS 2032)
2.4.3.2 Global Carbon-14 Radiosynthesis Services Market Size Market Share by Detection Method (2021-2026)
2.5 Carbon-14 Radiosynthesis Services Segment by Application
2.5.1 Medical
2.5.2 Chemical Research
2.5.3 Others
2.5.4 Carbon-14 Radiosynthesis Services Market Size by Application
2.5.4.1 Carbon-14 Radiosynthesis Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
3 CARBON-14 RADIOSYNTHESIS SERVICES MARKET SIZE BY PLAYER
3.1 Carbon-14 Radiosynthesis Services Market Size Market Share by Player
3.1.1 Global Carbon-14 Radiosynthesis Services Revenue by Player (2021-2026)
3.1.2 Global Carbon-14 Radiosynthesis Services Revenue Market Share by Player (2021-2026)
3.2 Global Carbon-14 Radiosynthesis Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CARBON-14 RADIOSYNTHESIS SERVICES BY REGION
4.1 Carbon-14 Radiosynthesis Services Market Size by Region (2021-2026)
4.2 Global Carbon-14 Radiosynthesis Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Carbon-14 Radiosynthesis Services Market Size Growth (2021-2026)
4.4 APAC Carbon-14 Radiosynthesis Services Market Size Growth (2021-2026)
4.5 Europe Carbon-14 Radiosynthesis Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Carbon-14 Radiosynthesis Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Carbon-14 Radiosynthesis Services Market Size by Country (2021-2026)
5.2 Americas Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026)
5.3 Americas Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Carbon-14 Radiosynthesis Services Market Size by Region (2021-2026)
6.2 APAC Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026)
6.3 APAC Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Carbon-14 Radiosynthesis Services Market Size by Country (2021-2026)
7.2 Europe Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026)
7.3 Europe Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Carbon-14 Radiosynthesis Services by Region (2021-2026)
8.2 Middle East & Africa Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CARBON-14 RADIOSYNTHESIS SERVICES MARKET FORECAST
10.1 Global Carbon-14 Radiosynthesis Services Forecast by Region (2027-2032)
10.1.1 Global Carbon-14 Radiosynthesis Services Forecast by Region (2027-2032)
10.1.2 Americas Carbon-14 Radiosynthesis Services Forecast
10.1.3 APAC Carbon-14 Radiosynthesis Services Forecast
10.1.4 Europe Carbon-14 Radiosynthesis Services Forecast
10.1.5 Middle East & Africa Carbon-14 Radiosynthesis Services Forecast
10.2 Americas Carbon-14 Radiosynthesis Services Forecast by Country (2027-2032)
10.2.1 United States Market Carbon-14 Radiosynthesis Services Forecast
10.2.2 Canada Market Carbon-14 Radiosynthesis Services Forecast
10.2.3 Mexico Market Carbon-14 Radiosynthesis Services Forecast
10.2.4 Brazil Market Carbon-14 Radiosynthesis Services Forecast
10.3 APAC Carbon-14 Radiosynthesis Services Forecast by Region (2027-2032)
10.3.1 China Carbon-14 Radiosynthesis Services Market Forecast
10.3.2 Japan Market Carbon-14 Radiosynthesis Services Forecast
10.3.3 Korea Market Carbon-14 Radiosynthesis Services Forecast
10.3.4 Southeast Asia Market Carbon-14 Radiosynthesis Services Forecast
10.3.5 India Market Carbon-14 Radiosynthesis Services Forecast
10.3.6 Australia Market Carbon-14 Radiosynthesis Services Forecast
10.4 Europe Carbon-14 Radiosynthesis Services Forecast by Country (2027-2032)
10.4.1 Germany Market Carbon-14 Radiosynthesis Services Forecast
10.4.2 France Market Carbon-14 Radiosynthesis Services Forecast
10.4.3 UK Market Carbon-14 Radiosynthesis Services Forecast
10.4.4 Italy Market Carbon-14 Radiosynthesis Services Forecast
10.4.5 Russia Market Carbon-14 Radiosynthesis Services Forecast
10.5 Middle East & Africa Carbon-14 Radiosynthesis Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Carbon-14 Radiosynthesis Services Forecast
10.5.2 South Africa Market Carbon-14 Radiosynthesis Services Forecast
10.5.3 Israel Market Carbon-14 Radiosynthesis Services Forecast
10.5.4 Turkey Market Carbon-14 Radiosynthesis Services Forecast
10.6 Global Carbon-14 Radiosynthesis Services Forecast by Type (2027-2032)
10.7 Global Carbon-14 Radiosynthesis Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Carbon-14 Radiosynthesis Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Eurofins
11.1.1 Eurofins Company Information
11.1.2 Eurofins Carbon-14 Radiosynthesis Services Product Offered
11.1.3 Eurofins Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Eurofins Main Business Overview
11.1.5 Eurofins Latest Developments
11.2 Revvity
11.2.1 Revvity Company Information
11.2.2 Revvity Carbon-14 Radiosynthesis Services Product Offered
11.2.3 Revvity Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Revvity Main Business Overview
11.2.5 Revvity Latest Developments
11.3 Selcia
11.3.1 Selcia Company Information
11.3.2 Selcia Carbon-14 Radiosynthesis Services Product Offered
11.3.3 Selcia Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Selcia Main Business Overview
11.3.5 Selcia Latest Developments
11.4 Novandi Chemistry
11.4.1 Novandi Chemistry Company Information
11.4.2 Novandi Chemistry Carbon-14 Radiosynthesis Services Product Offered
11.4.3 Novandi Chemistry Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novandi Chemistry Main Business Overview
11.4.5 Novandi Chemistry Latest Developments
11.5 Almac
11.5.1 Almac Company Information
11.5.2 Almac Carbon-14 Radiosynthesis Services Product Offered
11.5.3 Almac Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Almac Main Business Overview
11.5.5 Almac Latest Developments
11.6 Pharmaron
11.6.1 Pharmaron Company Information
11.6.2 Pharmaron Carbon-14 Radiosynthesis Services Product Offered
11.6.3 Pharmaron Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pharmaron Main Business Overview
11.6.5 Pharmaron Latest Developments
11.7 WuXi AppTec
11.7.1 WuXi AppTec Company Information
11.7.2 WuXi AppTec Carbon-14 Radiosynthesis Services Product Offered
11.7.3 WuXi AppTec Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 WuXi AppTec Main Business Overview
11.7.5 WuXi AppTec Latest Developments
11.8 Nuvisan
11.8.1 Nuvisan Company Information
11.8.2 Nuvisan Carbon-14 Radiosynthesis Services Product Offered
11.8.3 Nuvisan Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Nuvisan Main Business Overview
11.8.5 Nuvisan Latest Developments
11.9 Alfa Cytology
11.9.1 Alfa Cytology Company Information
11.9.2 Alfa Cytology Carbon-14 Radiosynthesis Services Product Offered
11.9.3 Alfa Cytology Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Alfa Cytology Main Business Overview
11.9.5 Alfa Cytology Latest Developments
11.10 Headway
11.10.1 Headway Company Information
11.10.2 Headway Carbon-14 Radiosynthesis Services Product Offered
11.10.3 Headway Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Headway Main Business Overview
11.10.5 Headway Latest Developments
11.11 ViTrax
11.11.1 ViTrax Company Information
11.11.2 ViTrax Carbon-14 Radiosynthesis Services Product Offered
11.11.3 ViTrax Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 ViTrax Main Business Overview
11.11.5 ViTrax Latest Developments
11.12 Beita Pharmatech Co., Ltd.
11.12.1 Beita Pharmatech Co., Ltd. Company Information
11.12.2 Beita Pharmatech Co., Ltd. Carbon-14 Radiosynthesis Services Product Offered
11.12.3 Beita Pharmatech Co., Ltd. Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Beita Pharmatech Co., Ltd. Main Business Overview
11.12.5 Beita Pharmatech Co., Ltd. Latest Developments
11.13 Moravek, Inc.
11.13.1 Moravek, Inc. Company Information
11.13.2 Moravek, Inc. Carbon-14 Radiosynthesis Services Product Offered
11.13.3 Moravek, Inc. Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Moravek, Inc. Main Business Overview
11.13.5 Moravek, Inc. Latest Developments
11.14 Labcorp
11.14.1 Labcorp Company Information
11.14.2 Labcorp Carbon-14 Radiosynthesis Services Product Offered
11.14.3 Labcorp Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Labcorp Main Business Overview
11.14.5 Labcorp Latest Developments
11.15 American Radiolabeled Chemicals, Inc.
11.15.1 American Radiolabeled Chemicals, Inc. Company Information
11.15.2 American Radiolabeled Chemicals, Inc. Carbon-14 Radiosynthesis Services Product Offered
11.15.3 American Radiolabeled Chemicals, Inc. Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 American Radiolabeled Chemicals, Inc. Main Business Overview
11.15.5 American Radiolabeled Chemicals, Inc. Latest Developments
11.16 Frontage Laboratories
11.16.1 Frontage Laboratories Company Information
11.16.2 Frontage Laboratories Carbon-14 Radiosynthesis Services Product Offered
11.16.3 Frontage Laboratories Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Frontage Laboratories Main Business Overview
11.16.5 Frontage Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Carbon-14 Radiosynthesis Services Market Size (2021-2032)
2.1.2 Carbon-14 Radiosynthesis Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Carbon-14 Radiosynthesis Services by Country/Region (2021, 2025 & 2032)
2.2 Carbon-14 Radiosynthesis Services Segment by Type
2.2.1 GMP - Compliant Services
2.2.2 Non - GMP Services
2.2.3 Carbon-14 Radiosynthesis Services Market Size by Type
2.2.3.1 Carbon-14 Radiosynthesis Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
2.3 Carbon-14 Radiosynthesis Services Segment by Compounds Type
2.3.1 Volatile Compounds
2.3.2 Aromatics and Heterocyclics
2.3.3 Other
2.3.4 Carbon-14 Radiosynthesis Services Market Size by Compounds Type
2.3.4.1 Carbon-14 Radiosynthesis Services Market Size CAGR by Compounds Type (2021 VS 2025 VS 2032)
2.3.4.2 Global Carbon-14 Radiosynthesis Services Market Size Market Share by Compounds Type (2021-2026)
2.4 Carbon-14 Radiosynthesis Services Segment by Detection Method
2.4.1 Liquid Scintillation and Solid Scintillation Methods
2.4.2 Ionization Method
2.4.3 Carbon-14 Radiosynthesis Services Market Size by Detection Method
2.4.3.1 Carbon-14 Radiosynthesis Services Market Size CAGR by Detection Method (2021 VS 2025 VS 2032)
2.4.3.2 Global Carbon-14 Radiosynthesis Services Market Size Market Share by Detection Method (2021-2026)
2.5 Carbon-14 Radiosynthesis Services Segment by Application
2.5.1 Medical
2.5.2 Chemical Research
2.5.3 Others
2.5.4 Carbon-14 Radiosynthesis Services Market Size by Application
2.5.4.1 Carbon-14 Radiosynthesis Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
3 CARBON-14 RADIOSYNTHESIS SERVICES MARKET SIZE BY PLAYER
3.1 Carbon-14 Radiosynthesis Services Market Size Market Share by Player
3.1.1 Global Carbon-14 Radiosynthesis Services Revenue by Player (2021-2026)
3.1.2 Global Carbon-14 Radiosynthesis Services Revenue Market Share by Player (2021-2026)
3.2 Global Carbon-14 Radiosynthesis Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CARBON-14 RADIOSYNTHESIS SERVICES BY REGION
4.1 Carbon-14 Radiosynthesis Services Market Size by Region (2021-2026)
4.2 Global Carbon-14 Radiosynthesis Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Carbon-14 Radiosynthesis Services Market Size Growth (2021-2026)
4.4 APAC Carbon-14 Radiosynthesis Services Market Size Growth (2021-2026)
4.5 Europe Carbon-14 Radiosynthesis Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Carbon-14 Radiosynthesis Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Carbon-14 Radiosynthesis Services Market Size by Country (2021-2026)
5.2 Americas Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026)
5.3 Americas Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Carbon-14 Radiosynthesis Services Market Size by Region (2021-2026)
6.2 APAC Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026)
6.3 APAC Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Carbon-14 Radiosynthesis Services Market Size by Country (2021-2026)
7.2 Europe Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026)
7.3 Europe Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Carbon-14 Radiosynthesis Services by Region (2021-2026)
8.2 Middle East & Africa Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CARBON-14 RADIOSYNTHESIS SERVICES MARKET FORECAST
10.1 Global Carbon-14 Radiosynthesis Services Forecast by Region (2027-2032)
10.1.1 Global Carbon-14 Radiosynthesis Services Forecast by Region (2027-2032)
10.1.2 Americas Carbon-14 Radiosynthesis Services Forecast
10.1.3 APAC Carbon-14 Radiosynthesis Services Forecast
10.1.4 Europe Carbon-14 Radiosynthesis Services Forecast
10.1.5 Middle East & Africa Carbon-14 Radiosynthesis Services Forecast
10.2 Americas Carbon-14 Radiosynthesis Services Forecast by Country (2027-2032)
10.2.1 United States Market Carbon-14 Radiosynthesis Services Forecast
10.2.2 Canada Market Carbon-14 Radiosynthesis Services Forecast
10.2.3 Mexico Market Carbon-14 Radiosynthesis Services Forecast
10.2.4 Brazil Market Carbon-14 Radiosynthesis Services Forecast
10.3 APAC Carbon-14 Radiosynthesis Services Forecast by Region (2027-2032)
10.3.1 China Carbon-14 Radiosynthesis Services Market Forecast
10.3.2 Japan Market Carbon-14 Radiosynthesis Services Forecast
10.3.3 Korea Market Carbon-14 Radiosynthesis Services Forecast
10.3.4 Southeast Asia Market Carbon-14 Radiosynthesis Services Forecast
10.3.5 India Market Carbon-14 Radiosynthesis Services Forecast
10.3.6 Australia Market Carbon-14 Radiosynthesis Services Forecast
10.4 Europe Carbon-14 Radiosynthesis Services Forecast by Country (2027-2032)
10.4.1 Germany Market Carbon-14 Radiosynthesis Services Forecast
10.4.2 France Market Carbon-14 Radiosynthesis Services Forecast
10.4.3 UK Market Carbon-14 Radiosynthesis Services Forecast
10.4.4 Italy Market Carbon-14 Radiosynthesis Services Forecast
10.4.5 Russia Market Carbon-14 Radiosynthesis Services Forecast
10.5 Middle East & Africa Carbon-14 Radiosynthesis Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Carbon-14 Radiosynthesis Services Forecast
10.5.2 South Africa Market Carbon-14 Radiosynthesis Services Forecast
10.5.3 Israel Market Carbon-14 Radiosynthesis Services Forecast
10.5.4 Turkey Market Carbon-14 Radiosynthesis Services Forecast
10.6 Global Carbon-14 Radiosynthesis Services Forecast by Type (2027-2032)
10.7 Global Carbon-14 Radiosynthesis Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Carbon-14 Radiosynthesis Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Eurofins
11.1.1 Eurofins Company Information
11.1.2 Eurofins Carbon-14 Radiosynthesis Services Product Offered
11.1.3 Eurofins Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Eurofins Main Business Overview
11.1.5 Eurofins Latest Developments
11.2 Revvity
11.2.1 Revvity Company Information
11.2.2 Revvity Carbon-14 Radiosynthesis Services Product Offered
11.2.3 Revvity Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Revvity Main Business Overview
11.2.5 Revvity Latest Developments
11.3 Selcia
11.3.1 Selcia Company Information
11.3.2 Selcia Carbon-14 Radiosynthesis Services Product Offered
11.3.3 Selcia Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Selcia Main Business Overview
11.3.5 Selcia Latest Developments
11.4 Novandi Chemistry
11.4.1 Novandi Chemistry Company Information
11.4.2 Novandi Chemistry Carbon-14 Radiosynthesis Services Product Offered
11.4.3 Novandi Chemistry Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novandi Chemistry Main Business Overview
11.4.5 Novandi Chemistry Latest Developments
11.5 Almac
11.5.1 Almac Company Information
11.5.2 Almac Carbon-14 Radiosynthesis Services Product Offered
11.5.3 Almac Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Almac Main Business Overview
11.5.5 Almac Latest Developments
11.6 Pharmaron
11.6.1 Pharmaron Company Information
11.6.2 Pharmaron Carbon-14 Radiosynthesis Services Product Offered
11.6.3 Pharmaron Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pharmaron Main Business Overview
11.6.5 Pharmaron Latest Developments
11.7 WuXi AppTec
11.7.1 WuXi AppTec Company Information
11.7.2 WuXi AppTec Carbon-14 Radiosynthesis Services Product Offered
11.7.3 WuXi AppTec Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 WuXi AppTec Main Business Overview
11.7.5 WuXi AppTec Latest Developments
11.8 Nuvisan
11.8.1 Nuvisan Company Information
11.8.2 Nuvisan Carbon-14 Radiosynthesis Services Product Offered
11.8.3 Nuvisan Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Nuvisan Main Business Overview
11.8.5 Nuvisan Latest Developments
11.9 Alfa Cytology
11.9.1 Alfa Cytology Company Information
11.9.2 Alfa Cytology Carbon-14 Radiosynthesis Services Product Offered
11.9.3 Alfa Cytology Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Alfa Cytology Main Business Overview
11.9.5 Alfa Cytology Latest Developments
11.10 Headway
11.10.1 Headway Company Information
11.10.2 Headway Carbon-14 Radiosynthesis Services Product Offered
11.10.3 Headway Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Headway Main Business Overview
11.10.5 Headway Latest Developments
11.11 ViTrax
11.11.1 ViTrax Company Information
11.11.2 ViTrax Carbon-14 Radiosynthesis Services Product Offered
11.11.3 ViTrax Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 ViTrax Main Business Overview
11.11.5 ViTrax Latest Developments
11.12 Beita Pharmatech Co., Ltd.
11.12.1 Beita Pharmatech Co., Ltd. Company Information
11.12.2 Beita Pharmatech Co., Ltd. Carbon-14 Radiosynthesis Services Product Offered
11.12.3 Beita Pharmatech Co., Ltd. Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Beita Pharmatech Co., Ltd. Main Business Overview
11.12.5 Beita Pharmatech Co., Ltd. Latest Developments
11.13 Moravek, Inc.
11.13.1 Moravek, Inc. Company Information
11.13.2 Moravek, Inc. Carbon-14 Radiosynthesis Services Product Offered
11.13.3 Moravek, Inc. Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Moravek, Inc. Main Business Overview
11.13.5 Moravek, Inc. Latest Developments
11.14 Labcorp
11.14.1 Labcorp Company Information
11.14.2 Labcorp Carbon-14 Radiosynthesis Services Product Offered
11.14.3 Labcorp Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Labcorp Main Business Overview
11.14.5 Labcorp Latest Developments
11.15 American Radiolabeled Chemicals, Inc.
11.15.1 American Radiolabeled Chemicals, Inc. Company Information
11.15.2 American Radiolabeled Chemicals, Inc. Carbon-14 Radiosynthesis Services Product Offered
11.15.3 American Radiolabeled Chemicals, Inc. Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 American Radiolabeled Chemicals, Inc. Main Business Overview
11.15.5 American Radiolabeled Chemicals, Inc. Latest Developments
11.16 Frontage Laboratories
11.16.1 Frontage Laboratories Company Information
11.16.2 Frontage Laboratories Carbon-14 Radiosynthesis Services Product Offered
11.16.3 Frontage Laboratories Carbon-14 Radiosynthesis Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Frontage Laboratories Main Business Overview
11.16.5 Frontage Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Carbon-14 Radiosynthesis Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Carbon-14 Radiosynthesis Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of GMP - Compliant Services
Table 4. Major Players of Non - GMP Services
Table 5. Carbon-14 Radiosynthesis Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Volatile Compounds
Table 9. Major Players of Aromatics and Heterocyclics
Table 10. Major Players of Other
Table 11. Carbon-14 Radiosynthesis Services Market Size CAGR by Compounds Type (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Carbon-14 Radiosynthesis Services Market Size by Compounds Type (2021-2026) & ($ millions)
Table 13. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Compounds Type (2021-2026)
Table 14. Major Players of Liquid Scintillation and Solid Scintillation Methods
Table 15. Major Players of Ionization Method
Table 16. Carbon-14 Radiosynthesis Services Market Size CAGR by Detection Method (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Carbon-14 Radiosynthesis Services Market Size by Detection Method (2021-2026) & ($ millions)
Table 18. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Detection Method (2021-2026)
Table 19. Carbon-14 Radiosynthesis Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026) & ($ millions)
Table 21. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
Table 22. Global Carbon-14 Radiosynthesis Services Revenue by Player (2021-2026) & ($ millions)
Table 23. Global Carbon-14 Radiosynthesis Services Revenue Market Share by Player (2021-2026)
Table 24. Carbon-14 Radiosynthesis Services Key Players Head office and Products Offered
Table 25. Carbon-14 Radiosynthesis Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Carbon-14 Radiosynthesis Services Market Size by Region (2021-2026) & ($ millions)
Table 29. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Region (2021-2026)
Table 30. Global Carbon-14 Radiosynthesis Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global Carbon-14 Radiosynthesis Services Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas Carbon-14 Radiosynthesis Services Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas Carbon-14 Radiosynthesis Services Market Size Market Share by Country (2021-2026)
Table 34. Americas Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026) & ($ millions)
Table 35. Americas Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
Table 36. Americas Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
Table 38. APAC Carbon-14 Radiosynthesis Services Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC Carbon-14 Radiosynthesis Services Market Size Market Share by Region (2021-2026)
Table 40. APAC Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026) & ($ millions)
Table 41. APAC Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe Carbon-14 Radiosynthesis Services Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe Carbon-14 Radiosynthesis Services Market Size Market Share by Country (2021-2026)
Table 44. Europe Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026) & ($ millions)
Table 45. Europe Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026) & ($ millions)
Table 48. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of Carbon-14 Radiosynthesis Services
Table 50. Key Market Challenges & Risks of Carbon-14 Radiosynthesis Services
Table 51. Key Industry Trends of Carbon-14 Radiosynthesis Services
Table 52. Global Carbon-14 Radiosynthesis Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global Carbon-14 Radiosynthesis Services Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global Carbon-14 Radiosynthesis Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 55. Global Carbon-14 Radiosynthesis Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. Eurofins Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 57. Eurofins Carbon-14 Radiosynthesis Services Product Offered
Table 58. Eurofins Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Eurofins Main Business
Table 60. Eurofins Latest Developments
Table 61. Revvity Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 62. Revvity Carbon-14 Radiosynthesis Services Product Offered
Table 63. Revvity Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Revvity Main Business
Table 65. Revvity Latest Developments
Table 66. Selcia Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 67. Selcia Carbon-14 Radiosynthesis Services Product Offered
Table 68. Selcia Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Selcia Main Business
Table 70. Selcia Latest Developments
Table 71. Novandi Chemistry Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 72. Novandi Chemistry Carbon-14 Radiosynthesis Services Product Offered
Table 73. Novandi Chemistry Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Novandi Chemistry Main Business
Table 75. Novandi Chemistry Latest Developments
Table 76. Almac Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 77. Almac Carbon-14 Radiosynthesis Services Product Offered
Table 78. Almac Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Almac Main Business
Table 80. Almac Latest Developments
Table 81. Pharmaron Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 82. Pharmaron Carbon-14 Radiosynthesis Services Product Offered
Table 83. Pharmaron Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Pharmaron Main Business
Table 85. Pharmaron Latest Developments
Table 86. WuXi AppTec Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 87. WuXi AppTec Carbon-14 Radiosynthesis Services Product Offered
Table 88. WuXi AppTec Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. WuXi AppTec Main Business
Table 90. WuXi AppTec Latest Developments
Table 91. Nuvisan Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 92. Nuvisan Carbon-14 Radiosynthesis Services Product Offered
Table 93. Nuvisan Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Nuvisan Main Business
Table 95. Nuvisan Latest Developments
Table 96. Alfa Cytology Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 97. Alfa Cytology Carbon-14 Radiosynthesis Services Product Offered
Table 98. Alfa Cytology Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Alfa Cytology Main Business
Table 100. Alfa Cytology Latest Developments
Table 101. Headway Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 102. Headway Carbon-14 Radiosynthesis Services Product Offered
Table 103. Headway Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Headway Main Business
Table 105. Headway Latest Developments
Table 106. ViTrax Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 107. ViTrax Carbon-14 Radiosynthesis Services Product Offered
Table 108. ViTrax Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. ViTrax Main Business
Table 110. ViTrax Latest Developments
Table 111. Beita Pharmatech Co., Ltd. Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 112. Beita Pharmatech Co., Ltd. Carbon-14 Radiosynthesis Services Product Offered
Table 113. Beita Pharmatech Co., Ltd. Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Beita Pharmatech Co., Ltd. Main Business
Table 115. Beita Pharmatech Co., Ltd. Latest Developments
Table 116. Moravek, Inc. Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 117. Moravek, Inc. Carbon-14 Radiosynthesis Services Product Offered
Table 118. Moravek, Inc. Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Moravek, Inc. Main Business
Table 120. Moravek, Inc. Latest Developments
Table 121. Labcorp Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 122. Labcorp Carbon-14 Radiosynthesis Services Product Offered
Table 123. Labcorp Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Labcorp Main Business
Table 125. Labcorp Latest Developments
Table 126. American Radiolabeled Chemicals, Inc. Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 127. American Radiolabeled Chemicals, Inc. Carbon-14 Radiosynthesis Services Product Offered
Table 128. American Radiolabeled Chemicals, Inc. Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. American Radiolabeled Chemicals, Inc. Main Business
Table 130. American Radiolabeled Chemicals, Inc. Latest Developments
Table 131. Frontage Laboratories Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 132. Frontage Laboratories Carbon-14 Radiosynthesis Services Product Offered
Table 133. Frontage Laboratories Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Frontage Laboratories Main Business
Table 135. Frontage Laboratories Latest Developments
Table 1. Carbon-14 Radiosynthesis Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Carbon-14 Radiosynthesis Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of GMP - Compliant Services
Table 4. Major Players of Non - GMP Services
Table 5. Carbon-14 Radiosynthesis Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Volatile Compounds
Table 9. Major Players of Aromatics and Heterocyclics
Table 10. Major Players of Other
Table 11. Carbon-14 Radiosynthesis Services Market Size CAGR by Compounds Type (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Carbon-14 Radiosynthesis Services Market Size by Compounds Type (2021-2026) & ($ millions)
Table 13. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Compounds Type (2021-2026)
Table 14. Major Players of Liquid Scintillation and Solid Scintillation Methods
Table 15. Major Players of Ionization Method
Table 16. Carbon-14 Radiosynthesis Services Market Size CAGR by Detection Method (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Carbon-14 Radiosynthesis Services Market Size by Detection Method (2021-2026) & ($ millions)
Table 18. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Detection Method (2021-2026)
Table 19. Carbon-14 Radiosynthesis Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026) & ($ millions)
Table 21. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
Table 22. Global Carbon-14 Radiosynthesis Services Revenue by Player (2021-2026) & ($ millions)
Table 23. Global Carbon-14 Radiosynthesis Services Revenue Market Share by Player (2021-2026)
Table 24. Carbon-14 Radiosynthesis Services Key Players Head office and Products Offered
Table 25. Carbon-14 Radiosynthesis Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Carbon-14 Radiosynthesis Services Market Size by Region (2021-2026) & ($ millions)
Table 29. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Region (2021-2026)
Table 30. Global Carbon-14 Radiosynthesis Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global Carbon-14 Radiosynthesis Services Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas Carbon-14 Radiosynthesis Services Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas Carbon-14 Radiosynthesis Services Market Size Market Share by Country (2021-2026)
Table 34. Americas Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026) & ($ millions)
Table 35. Americas Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
Table 36. Americas Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
Table 38. APAC Carbon-14 Radiosynthesis Services Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC Carbon-14 Radiosynthesis Services Market Size Market Share by Region (2021-2026)
Table 40. APAC Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026) & ($ millions)
Table 41. APAC Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe Carbon-14 Radiosynthesis Services Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe Carbon-14 Radiosynthesis Services Market Size Market Share by Country (2021-2026)
Table 44. Europe Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026) & ($ millions)
Table 45. Europe Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size by Type (2021-2026) & ($ millions)
Table 48. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of Carbon-14 Radiosynthesis Services
Table 50. Key Market Challenges & Risks of Carbon-14 Radiosynthesis Services
Table 51. Key Industry Trends of Carbon-14 Radiosynthesis Services
Table 52. Global Carbon-14 Radiosynthesis Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global Carbon-14 Radiosynthesis Services Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global Carbon-14 Radiosynthesis Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 55. Global Carbon-14 Radiosynthesis Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. Eurofins Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 57. Eurofins Carbon-14 Radiosynthesis Services Product Offered
Table 58. Eurofins Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Eurofins Main Business
Table 60. Eurofins Latest Developments
Table 61. Revvity Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 62. Revvity Carbon-14 Radiosynthesis Services Product Offered
Table 63. Revvity Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Revvity Main Business
Table 65. Revvity Latest Developments
Table 66. Selcia Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 67. Selcia Carbon-14 Radiosynthesis Services Product Offered
Table 68. Selcia Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Selcia Main Business
Table 70. Selcia Latest Developments
Table 71. Novandi Chemistry Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 72. Novandi Chemistry Carbon-14 Radiosynthesis Services Product Offered
Table 73. Novandi Chemistry Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Novandi Chemistry Main Business
Table 75. Novandi Chemistry Latest Developments
Table 76. Almac Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 77. Almac Carbon-14 Radiosynthesis Services Product Offered
Table 78. Almac Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Almac Main Business
Table 80. Almac Latest Developments
Table 81. Pharmaron Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 82. Pharmaron Carbon-14 Radiosynthesis Services Product Offered
Table 83. Pharmaron Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Pharmaron Main Business
Table 85. Pharmaron Latest Developments
Table 86. WuXi AppTec Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 87. WuXi AppTec Carbon-14 Radiosynthesis Services Product Offered
Table 88. WuXi AppTec Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. WuXi AppTec Main Business
Table 90. WuXi AppTec Latest Developments
Table 91. Nuvisan Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 92. Nuvisan Carbon-14 Radiosynthesis Services Product Offered
Table 93. Nuvisan Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Nuvisan Main Business
Table 95. Nuvisan Latest Developments
Table 96. Alfa Cytology Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 97. Alfa Cytology Carbon-14 Radiosynthesis Services Product Offered
Table 98. Alfa Cytology Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Alfa Cytology Main Business
Table 100. Alfa Cytology Latest Developments
Table 101. Headway Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 102. Headway Carbon-14 Radiosynthesis Services Product Offered
Table 103. Headway Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Headway Main Business
Table 105. Headway Latest Developments
Table 106. ViTrax Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 107. ViTrax Carbon-14 Radiosynthesis Services Product Offered
Table 108. ViTrax Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. ViTrax Main Business
Table 110. ViTrax Latest Developments
Table 111. Beita Pharmatech Co., Ltd. Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 112. Beita Pharmatech Co., Ltd. Carbon-14 Radiosynthesis Services Product Offered
Table 113. Beita Pharmatech Co., Ltd. Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Beita Pharmatech Co., Ltd. Main Business
Table 115. Beita Pharmatech Co., Ltd. Latest Developments
Table 116. Moravek, Inc. Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 117. Moravek, Inc. Carbon-14 Radiosynthesis Services Product Offered
Table 118. Moravek, Inc. Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Moravek, Inc. Main Business
Table 120. Moravek, Inc. Latest Developments
Table 121. Labcorp Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 122. Labcorp Carbon-14 Radiosynthesis Services Product Offered
Table 123. Labcorp Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Labcorp Main Business
Table 125. Labcorp Latest Developments
Table 126. American Radiolabeled Chemicals, Inc. Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 127. American Radiolabeled Chemicals, Inc. Carbon-14 Radiosynthesis Services Product Offered
Table 128. American Radiolabeled Chemicals, Inc. Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. American Radiolabeled Chemicals, Inc. Main Business
Table 130. American Radiolabeled Chemicals, Inc. Latest Developments
Table 131. Frontage Laboratories Details, Company Type, Carbon-14 Radiosynthesis Services Area Served and Its Competitors
Table 132. Frontage Laboratories Carbon-14 Radiosynthesis Services Product Offered
Table 133. Frontage Laboratories Carbon-14 Radiosynthesis Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Frontage Laboratories Main Business
Table 135. Frontage Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Carbon-14 Radiosynthesis Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Carbon-14 Radiosynthesis Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Carbon-14 Radiosynthesis Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Carbon-14 Radiosynthesis Services Sales Market Share by Country/Region (2025)
Figure 8. Carbon-14 Radiosynthesis Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Type in 2025
Figure 10. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Compounds Type in 2025
Figure 11. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Detection Method in 2025
Figure 12. Carbon-14 Radiosynthesis Services in Medical
Figure 13. Global Carbon-14 Radiosynthesis Services Market: Medical (2021-2026) & ($ millions)
Figure 14. Carbon-14 Radiosynthesis Services in Chemical Research
Figure 15. Global Carbon-14 Radiosynthesis Services Market: Chemical Research (2021-2026) & ($ millions)
Figure 16. Carbon-14 Radiosynthesis Services in Others
Figure 17. Global Carbon-14 Radiosynthesis Services Market: Others (2021-2026) & ($ millions)
Figure 18. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Application in 2025
Figure 19. Global Carbon-14 Radiosynthesis Services Revenue Market Share by Player in 2025
Figure 20. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Region (2021-2026)
Figure 21. Americas Carbon-14 Radiosynthesis Services Market Size 2021-2026 ($ millions)
Figure 22. APAC Carbon-14 Radiosynthesis Services Market Size 2021-2026 ($ millions)
Figure 23. Europe Carbon-14 Radiosynthesis Services Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size 2021-2026 ($ millions)
Figure 25. Americas Carbon-14 Radiosynthesis Services Value Market Share by Country in 2025
Figure 26. United States Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Carbon-14 Radiosynthesis Services Market Size Market Share by Region in 2025
Figure 31. APAC Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
Figure 32. APAC Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
Figure 33. China Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 37. India Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Carbon-14 Radiosynthesis Services Market Size Market Share by Country in 2025
Figure 40. Europe Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
Figure 41. Europe Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
Figure 42. Germany Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 43. France Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 56. APAC Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 57. Europe Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 59. United States Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 60. Canada Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 61. Mexico Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 62. Brazil Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 63. China Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 64. Japan Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 65. Korea Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 67. India Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 68. Australia Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 69. Germany Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 70. France Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 71. UK Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 72. Italy Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 73. Russia Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 74. Egypt Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 75. South Africa Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 76. Israel Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 77. Turkey Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 78. Global Carbon-14 Radiosynthesis Services Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Carbon-14 Radiosynthesis Services Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 1. Carbon-14 Radiosynthesis Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Carbon-14 Radiosynthesis Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Carbon-14 Radiosynthesis Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Carbon-14 Radiosynthesis Services Sales Market Share by Country/Region (2025)
Figure 8. Carbon-14 Radiosynthesis Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Type in 2025
Figure 10. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Compounds Type in 2025
Figure 11. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Detection Method in 2025
Figure 12. Carbon-14 Radiosynthesis Services in Medical
Figure 13. Global Carbon-14 Radiosynthesis Services Market: Medical (2021-2026) & ($ millions)
Figure 14. Carbon-14 Radiosynthesis Services in Chemical Research
Figure 15. Global Carbon-14 Radiosynthesis Services Market: Chemical Research (2021-2026) & ($ millions)
Figure 16. Carbon-14 Radiosynthesis Services in Others
Figure 17. Global Carbon-14 Radiosynthesis Services Market: Others (2021-2026) & ($ millions)
Figure 18. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Application in 2025
Figure 19. Global Carbon-14 Radiosynthesis Services Revenue Market Share by Player in 2025
Figure 20. Global Carbon-14 Radiosynthesis Services Market Size Market Share by Region (2021-2026)
Figure 21. Americas Carbon-14 Radiosynthesis Services Market Size 2021-2026 ($ millions)
Figure 22. APAC Carbon-14 Radiosynthesis Services Market Size 2021-2026 ($ millions)
Figure 23. Europe Carbon-14 Radiosynthesis Services Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size 2021-2026 ($ millions)
Figure 25. Americas Carbon-14 Radiosynthesis Services Value Market Share by Country in 2025
Figure 26. United States Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Carbon-14 Radiosynthesis Services Market Size Market Share by Region in 2025
Figure 31. APAC Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
Figure 32. APAC Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
Figure 33. China Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 37. India Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Carbon-14 Radiosynthesis Services Market Size Market Share by Country in 2025
Figure 40. Europe Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
Figure 41. Europe Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
Figure 42. Germany Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 43. France Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Carbon-14 Radiosynthesis Services Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 56. APAC Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 57. Europe Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 59. United States Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 60. Canada Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 61. Mexico Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 62. Brazil Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 63. China Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 64. Japan Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 65. Korea Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 67. India Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 68. Australia Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 69. Germany Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 70. France Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 71. UK Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 72. Italy Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 73. Russia Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 74. Egypt Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 75. South Africa Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 76. Israel Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 77. Turkey Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
Figure 78. Global Carbon-14 Radiosynthesis Services Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Carbon-14 Radiosynthesis Services Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Carbon-14 Radiosynthesis Services Market Size 2027-2032 ($ millions)
